Proscience Research Group
ProScience Research Group is a privately held, boutique clinical research site in Culver City, California, conducting Phase I-IV CNS and mental health trials for pharmaceutical sponsors and CROs across inpatient and outpatient facilities, supported by a 10,000+ patient database.
- Company typePrivate
- Founded2019
- HeadquartersCulver City, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Proscience Research Group does
ProScience Research Group is a privately held, boutique clinical research site (CRS) specializing in Phase I-IV trials for central nervous system (CNS) disorders, including schizophrenia, major depression, bipolar disorder, ADHD, anxiety, insomnia, migraine, Alzheimer's, and PTSD. Founded around 2004 and headquartered in Culver City, California, the company operates an outpatient clinic near LAX, a 20-bed adult inpatient unit at Percy Gateways Village, and an adolescent inpatient unit at Gateways Hospital — providing the full spectrum of inpatient and outpatient CNS trial infrastructure, including a CLIA-accredited laboratory with ECG, EEG, serial PK sampling, and -20°C/-70°C freezer storage.
The company's core offering is contract clinical research services delivered to pharmaceutical sponsors and Contract Research Organizations (CROs), with revenue generated through per-study professional services agreements. Its competitive proposition rests on a 10,000+ patient volunteer database, an IRB-approved pre-screening protocol that materially reduces screen-fail rates, and a roster of board-certified psychiatrists and trained behavioral/cognitive raters. Notable personnel include Medical Director Dr. Marina Bussel (100+ trials as Principal Investigator) and Lead Consultant Dr. Larry Ereshefsky (former VP at PAREXEL International, 40-year CNS drug development track record).
The business model is a pure professional services CRO/site relationship: sponsors and CROs contract directly for trial execution, while patients are recruited through the company's website database, outbound phone outreach, and a $50-per-referral program. Patient-facing payment (compensation for time and transportation) is a study cost rather than revenue. The firm is physician-owned and closely held, with no disclosed external investment, parent company, or subsidiary structure.
Proscience Research Group firmographics
Firmographics- Name
- Proscience Research Group
- Legal name
- ProScience Research Group
- Website
- https://prosciencerg.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ProScience Research Group is a privately held, boutique clinical research site in Culver City, California, conducting Phase I-IV CNS and mental health trials for pharmaceutical sponsors and CROs across inpatient and outpatient facilities, supported by a 10,000+ patient database.
- Ownership category
- akta.pro rank
Proscience Research Group industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Proscience Research Group is headquartered
LocationHeadquarters
- HQ city
- Culver City
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Proscience Research Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Clinical Trial Services: ProScience Research Group provides clinical research services to pharmaceutical sponsors and CROs, conducting Phase I-IV clinical trials primarily in CNS (central nervous system) therapeutic areas. Revenue is generated through contracted research agreements with pharmaceutical companies seeking to test new or existing medications.
- Clinical Trial Participant Compensation: Participants in clinical trials are paid for their time and transportation. Payment is made by check after each completed study visit. The amount varies from study to study. This is a cost to the company rather than revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Participant compensation for time and transportation |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Proscience Research Group product offering
Product offeringCore offering
ProScience Research Group conducts Phase I-IV clinical trials specializing in central nervous system (CNS) and mental health conditions, including ADHD, Alzheimer's, Anxiety, Bipolar Disorder, Depression, Migraine, Schizoaffective Disorder, Schizophrenia, and PTSD. The company provides patient recruitment, screening, study conduct, laboratory services, and regulatory compliance through an outpatient clinic in Culver City and inpatient facilities in Los Angeles. It serves pharmaceutical sponsors and Contract Research Organizations (CROs), drawing from a database of 10,000+ patients and following Good Clinical Practice standards.
Product overview
ProScience Research Group is a clinical research organization (CRO) offering integrated Phase I-IV clinical trial services for CNS disorders. The company operates outpatient facilities in Culver City and inpatient facilities in Los Angeles, maintaining a database of 10,000+ patients. Services include participant screening, clinical assessments, laboratory services, and specialized rater evaluations. The organization focuses on mental health conditions including ADHD, Alzheimer's, Anxiety, Bipolar Disorder, Depression, Migraine, Schizoaffective Disorder, Schizophrenia, and PTSD.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Research Services Phase I-IV clinical trial services for pharmaceutical sponsors and CROs, specializing in central nervous system (CNS) disorders including ADHD, Alzheimer's, Anxiety, Bipolar Disorder, Depression, Migraine, Schizoaffective Disorder, Schizophrenia, and PTSD. Includes patient recruitment, screening, study conduct, data collection, safety monitoring, and regulatory compliance.
- Inpatient Clinical Trial Facility Inpatient research facility for adult participants (18+) at Percy Gateways Village near downtown Los Angeles with 20 patient beds, smoking area, and entertainment room, plus an adolescent inpatient facility at Gateways Hospital in downtown Los Angeles for participants under 18. Patient rooms are furnished with beds, flat screen TV, DVD player, walk-in closet, and bathroom.
- Outpatient Clinical Trial Facility Outpatient research clinic located in Culver City, approximately 3 miles from LAX airport. Includes patient waiting area, private patient exam rooms, CLIA-accredited laboratory with -20°C and -70°C freezers and refrigerated centrifuge, secured drug storage, and crash cart with CPR-certified staff.
Quantifiable outcome
- Over 100 trials completed as Principal Investigator by Dr. Bussel
- +4 more outcomes
Companies that use Proscience Research Group
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Proscience Research Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Proscience Research Group partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Percy Gateways VillagecoreInpatient facility near downtown Los Angeles where adult participants (18+) stay during clinical trials. The facility offers 20 patient beds, smoking area, entertainment room with activities, furnished patient rooms with flat screen TV and DVD player.
- Gateways Hospital and Mental Health CentercoreDowntown Los Angeles facility where adolescent participants (under 18) stay during inpatient studies. Dr. Arthur Kopp treats patients at this facility and serves on the Quality Assurance Committee.
- Cedars-Sinai Medical Center / UCLA School of MedicineminorDr. Marina Bussel completed her Psychiatry Residency Training and Child and Adolescent Psychiatry Fellowship Programs at Cedars-Sinai Medical Center affiliated with UCLA School of Medicine in Los Angeles.
- Columbia University Medical Center / New York Psychiatric InstituteminorDr. Marina Bussel completed the Public Psychiatry Fellowship at New York Psychiatric Institute affiliated with Columbia University Medical Center.
- Loma Linda University Medical CenterminorDr. Arthur Kopp completed his Addiction Medicine Fellowship at Loma Linda University Medical Center, gaining experience as a Research Physician in Phase II through Phase IV clinical trials.
- PAREXEL International (Former)minorDr. Larry Ereshefsky formerly served as VP and Global Leader for Early Phase CNS and Therapeutic Area Leader at PAREXEL International for 13 years, including as Chief Scientific Officer of California Clinical Trials.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Proscience Research Group competitors and assessment
Company assessmentDirect peers
- Hassman Research Institute (HRI): HRI is a small, CNS-focused clinical research site in New Jersey that conducts Phase I–IV psychiatry trials for pharmaceutical sponsors and CROs — directly comparable in size, therapeutic focus, and business model to ProScience.
- Atlanta Center for Medical Research: ACMR is an independent clinical research site running Phase I–IV trials including CNS and psychiatry indications — a directly comparable specialty research site competing for the same sponsor protocols.
- iResearch Atlanta: iResearch Atlanta is an independent clinical research site conducting CNS and psychiatry trials, directly comparable to ProScience as a small, sponsor-contracted Phase I–IV site with specialized therapeutic focus.
- Segal Trials: Segal Trials operates a network of psychiatry-focused clinical research sites across the U.S., running Phase I–IV CNS trials for sponsors and CROs — a multi-site peer competing for the same CNS protocols ProScience targets.
- Collaborative Neuroscience Network (CNS Network): CNS Network is a Southern California outpatient clinical research site specializing in CNS and psychiatry trials, directly overlapping with ProScience's CNS therapeutic focus and regional California footprint.
Broad incumbents
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO with deep CNS specialization across early- and late-phase trials; it competes with ProScience indirectly as the prime CRO whose site-management arm or preferred-site relationships can absorb work ProScience might otherwise win.
- IQVIA: IQVIA is the largest global CRO and operates a site-management network; it competes for CNS trial contracts and can offer sponsors one-stop site coverage that small independent sites like ProScience cannot match.
- Syneos Health: Syneos Health is a full-service biopharmaceutical services organization with CNS clinical capabilities and site-management solutions, comparable as a broad incumbent that competes for sponsor protocol allocation.
- PAREXEL International: PAREXEL is a global full-service CRO with extensive CNS capabilities — a sponsor-side counterpart that both contracts sites like ProScience and competes for CNS trial execution at larger scale.
Emerging players
- Signant Health: Signant Health (formed from the merger of MedAvante and CRF Health) provides CNS-rated eCOA and rater training services — adjacent but partial overlap with ProScience's experienced behavioral/cognitive rater capabilities for CNS trials.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Proscience Research Group social profiles
Digital presenceProscience Research Group compliance and trust
Trust signalCompliance2 records
Proscience Research Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Proscience Research Group leadership team
Management profileNumber of profiles
Profiles6 records
Proscience Research Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Proscience Research Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Proscience Research Group
What does Proscience Research Group do?
ProScience Research Group conducts Phase I-IV clinical trials specializing in central nervous system (CNS) and mental health conditions, including ADHD, Alzheimer's, Anxiety, Bipolar Disorder, Depression, Migraine, Schizoaffective Disorder, Schizophrenia, and PTSD. The company provides patient recruitment, screening, study conduct, laboratory services, and regulatory compliance through an outpatient clinic in Culver City and inpatient facilities in Los Angeles. It serves pharmaceutical sponsors and Contract Research Organizations (CROs), drawing from a database of 10,000+ patients and following Good Clinical Practice standards.
Is Proscience Research Group a public or private company?
Proscience Research Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Proscience Research Group founded?
Proscience Research Group was founded in 2019. It employs 1 to 10 people.
Where is Proscience Research Group based?
Proscience Research Group is headquartered in Culver City, United States, in the North America region.
How does Proscience Research Group make money?
Two revenue lines are on record. Clinical Trial Services are the primary driver. The others are clinical Trial Participant Compensation.
Who are Proscience Research Group's main competitors?
Direct peers on record are Hassman Research Institute (HRI), Atlanta Center for Medical Research, iResearch Atlanta, Segal Trials and Collaborative Neuroscience Network (CNS Network). Broad incumbents are Worldwide Clinical Trials, IQVIA, Syneos Health and PAREXEL International. Signant Health is listed as an emerging player.
Does Proscience Research Group have an API?
No public API is recorded for Proscience Research Group.
What industry is Proscience Research Group in?
Proscience Research Group's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 5417 and its SIC code is 8731.